OGT

OGT (Oxford Gene Technology) is a global leader in clinical and diagnostic genomic solutions, focusing on advanced technologies for genetic research and molecular medicine. The company offers a range of services, including the CytoSure range for cytogenetics, SureSeq NGS workflows for next-generation sequencing, and custom microarray services. OGT is dedicated to biomarker discovery, developing proprietary tools for identifying disease markers and holding patents licensed to major biotech firms. The company serves academic, clinical, and pharmaceutical sectors, collaborating with partners like the Wellcome Trust and Intelliseq. OGT emphasizes quality and responsibility, maintaining an integrated management system with multiple certifications. Its mission is to advance personalized medicine through innovative clinical genetics and diagnostic tools while supporting global health initiatives. OGT is committed to ethical practices and community well-being, aiming to improve health outcomes worldwide.

Biotechnology United Kingdom ~28 employees

Work at OGT in HR or recruiting? Claim this page

Employees
28
0% in the 3 months to Jun 2025
Revenue / employee
$750K
Revenue ~$21M
12-month attrition
13.5%
Tech: 0%
H1B sponsor
NA
Open jobs
4
Last 30 days

Headcount trend

OGT went from 26 employees in Jul 2023 to 28 in Jun 2025. Jan to Jun 2025: 2 people joined, 1 left.

Headcount data through Jun 2025

Org structure

Headcount by department

Other15
Sales7
Marketing3
Product1
Operations1
Success1

OGT FAQ

How many employees does OGT have?

OGT has about 28 employees, unchanged over the 3 months to Jun 2025.

What is OGT's revenue per employee?

OGT makes about $750K in revenue per employee, based on $21M annual revenue and 28 employees.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.